Literature DB >> 31419066

Time-Dependent Measurement of Nrf2-Regulated Antioxidant Response to Ionizing Radiation Toward Identifying Potential Protein Biomarkers for Acute Radiation Injury.

Kate Liu1, Elizabeth Singer2, Whitaker Cohn2, Ewa D Micewicz2, William H McBride3, Julian P Whitelegge2, Joseph A Loo1,4.   

Abstract

PURPOSE: Potential acute exposure to ionizing radiation in nuclear or radiological accidents presents complex mass casualty scenarios that demand prompt triage and treatment decisions. Due to delayed symptoms and varied response of radiation victims, there is an urgent need to develop robust biomarkers to assess the extent of injuries in individuals. EXPERIMENTAL
DESIGN: The transcription factor Nrf2 is the master of redox homeostasis and there is transcriptional evidence of Nrf2-dependent antioxidant response activation upon radiation. The biomarker potential of Nrf2-dependent downstream target enzymes is investigated by measuring their response in bone marrow extracted from C57Bl/6 and C3H mice of both genders for up to 4 days following 6 Gy total body irradiation using targeted MS.
RESULTS: Overall, C57Bl/6 mice have a stronger proteomic response than C3H mice. In both strains, male mice have more occurrences of upregulation in antioxidant enzymes than female mice. For C57Bl/6 male mice, three proteins show elevated abundances after radiation exposure: catalase, superoxide dismutase 1, and heme oxygenase 1. Across both strains and genders, glutathione S-transferase Mu 1 is consistently decreased. CONCLUSIONS AND CLINICAL RELEVANCE: This study provides the basis for future development of organ-specific protein biomarkers used in diagnostic blood test for radiation injury.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antioxidant response; bone marrow; gender difference; ionizing radiation; targeted proteomics

Mesh:

Substances:

Year:  2019        PMID: 31419066      PMCID: PMC7213060          DOI: 10.1002/prca.201900035

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  57 in total

1.  Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1.

Authors:  S G Cho; Y H Lee; H S Park; K Ryoo; K W Kang; J Park; S J Eom; M J Kim; T S Chang; S Y Choi; J Shim; Y Kim; M S Dong; M J Lee; S G Kim; H Ichijo; E J Choi
Journal:  J Biol Chem       Date:  2001-01-18       Impact factor: 5.157

2.  THE RESPONSE OF TWENTY-SEVEN INBRED STRAINS OF MICE TO DAILY DOSES OF WHOLE-BODY X-IRRADIATION.

Authors:  T H RODERICK
Journal:  Radiat Res       Date:  1963-12       Impact factor: 2.841

3.  Animal models for medical countermeasures to radiation exposure.

Authors:  Jacqueline P Williams; Stephen L Brown; George E Georges; Martin Hauer-Jensen; Richard P Hill; Amy K Huser; David G Kirsch; Thomas J Macvittie; Kathy A Mason; Meetha M Medhora; John E Moulder; Paul Okunieff; Mary F Otterson; Michael E Robbins; James B Smathers; William H McBride
Journal:  Radiat Res       Date:  2010-04       Impact factor: 2.841

4.  Qualis-SIS: automated standard curve generation and quality assessment for multiplexed targeted quantitative proteomic experiments with labeled standards.

Authors:  Yassene Mohammed; Andrew J Percy; Andrew G Chambers; Christoph H Borchers
Journal:  J Proteome Res       Date:  2015-01-16       Impact factor: 4.466

5.  Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels.

Authors:  Ying Chen; Howard G Shertzer; Scott N Schneider; Daniel W Nebert; Timothy P Dalton
Journal:  J Biol Chem       Date:  2005-08-04       Impact factor: 5.157

6.  A proteomic analysis of murine bone marrow and its response to ionizing radiation.

Authors:  Changwei Chen; Sally A Lorimore; Caroline A Evans; Antony D Whetton; Eric G Wright
Journal:  Proteomics       Date:  2005-11       Impact factor: 3.984

7.  Low-dose gamma-ray irradiation induces translocation of Nrf2 into nuclear in mouse macrophage RAW264.7 cells.

Authors:  Mitsutoshi Tsukimoto; Nana Tamaishi; Takujiro Homma; Shuji Kojima
Journal:  J Radiat Res       Date:  2010-04-12       Impact factor: 2.724

Review 8.  State-of-the-Art Advances in Radiation Biodosimetry for Mass Casualty Events Involving Radiation Exposure.

Authors:  Mary Sproull; Kevin Camphausen
Journal:  Radiat Res       Date:  2016-10-06       Impact factor: 2.841

9.  NRF2-mediated Notch pathway activation enhances hematopoietic reconstitution following myelosuppressive radiation.

Authors:  Jung-Hyun Kim; Rajesh K Thimmulappa; Vineet Kumar; Wanchang Cui; Sarvesh Kumar; Ponvijay Kombairaju; Hao Zhang; Joseph Margolick; William Matsui; Thomas Macvittie; Sanjay V Malhotra; Shyam Biswal
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

10.  Factors related to resistance to hematopoietic death in mice.

Authors:  N Mori; M Okumoto; M Yonezawa; R Nishikawa; Y Takamori; K Esaki
Journal:  J Radiat Res       Date:  1994-03       Impact factor: 2.724

View more
  3 in total

1.  Proteomics of Non-human Primate Plasma after Partial-body Radiation with Minimal Bone Marrow Sparing.

Authors:  Weiliang Huang; Jianshi Yu; Tian Liu; Amy E Defnet; Stephanie Zalesak; Ann M Farese; Thomas J MacVittie; Maureen A Kane
Journal:  Health Phys       Date:  2020-11       Impact factor: 2.922

2.  Effects of neutron radiation on Nrf2-regulated antioxidant defense systems in rat lens.

Authors:  Yueqin Chen; Jundong Feng; Jingyu Liu; Hao Zhou; Huiyao Luo; Chunyan Xue; Weiping Gao
Journal:  Exp Ther Med       Date:  2021-02-08       Impact factor: 2.447

3.  Identification of miRNA signatures associated with radiation-induced late lung injury in mice.

Authors:  Claude J Rogers; Agnes I Lukaszewicz; Jason Yamada-Hanff; Ewa D Micewicz; Josephine A Ratikan; Mark A Starbird; Thomas A Miller; Christine Nguyen; Jason T Lee; Tove Olafsen; Keisuke S Iwamoto; William H McBride; Dörthe Schaue; Naresh Menon
Journal:  PLoS One       Date:  2020-05-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.